Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 18, Issue 2, 2001, Pages 169-177

  Xin Wei Wang, ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; HBx; Hepatitis B virus; Liver cancer; Microinjection; p53

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROINJECTION; NONHUMAN; PROTEIN INTERACTION; VIRUS GENE;

APOPTOSIS; BIOLOGICAL ASSAY; CELLS, CULTURED; FIBROBLASTS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICROINJECTIONS; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034933317     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:18:2:169     Document Type: Article

References (79)

1. Hepatocellular carcinoma
2. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
3. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma
4. Hepatitis B virus. The major etiology of hepatocellular carcinoma
5. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks
6. Woodchuck hepatitis virus X protein is required for viral infection in vivo
7. Genetic heterogeneity of hepatocellular carcinoma
8. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
9. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
10. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells
11. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA
12. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene
13. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
14. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts
15. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls
16. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit
17. Proteasome complex as a potential cellular target of hepatitis B virus X protein
18. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome
19. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein
20. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH
21. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
22. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
23. Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis
24. Direct inhibition of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation
25. Expression of the hepatitis B virus X gene in mammalian cells
26. Transcriptional trans-activating function of hepatitis B virus
27. Trans-activation of viral enhancers by the hepatitis B virus X protein
28. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein
29. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1
30. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication
31. Hepatitis B virus X gene can transactivate heterologous viral sequences
32. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2
33. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C
34. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters
35. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases
36. Activation of protooncogene c-jun by the X protein of hepatitis B virus
37. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C
38. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX
39. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
40. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB
41. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation
42. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein
43. Hepatitis B virus transactivator HBx uses. A tumour promoter signaling pathway
44. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
45. Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway
46. The hepatitis B virus X gene induces p53-mediated programmed cell death
47. X-gene product of hepatitis B virus induces apoptosis in liver cells
48. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha
49. Cancer. p53, guardian of the genome
50. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia
51. p53 and Its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
52. p53 Modulation of TFIIH-associated nucleotide excision repair activity
53. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
54. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
55. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
56. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
57. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
58. Thymocyte apoptosis induced by p53-dependent and independent pathways
59. p53 is required for radiation-induced apoptosis in mouse thymocytes
60. p53-Dependent apoptosis suppresses tumor growth and progression in vivo
61. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
62. p53 Mutations in human cancers
63. The p53 tumour suppressor gene
64. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
65. p53 Mutations increase resistance to ionizing radiation
66. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
67. p53 Status and the efficacy of cancer therapy in vivo
68. TP53 tumour suppressor gene: Clues to molecular carcinogenesis and cancer therapy
69. Functional inactivation but not structural mutation of p53 causes liver cancer
70. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
71. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct
72. The XPB and XPD helicases are components of the p53-mediated apoptosis pathway
73. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
74. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system
75. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells
76. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas
77. Mutant p53 but not Hepatitis B virus X protein is present in Hepatitis B virus-related human hepatocellular carcinoma
78. Integrity of p53 in hepatitis B x antigen-positive and-negative hepatocellular carcinomas
79. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest